280 related articles for article (PubMed ID: 22618245)
41. Nox as a target for diabetic complications.
Gorin Y; Block K
Clin Sci (Lond); 2013 Oct; 125(8):361-82. PubMed ID: 23767990
[TBL] [Abstract][Full Text] [Related]
42. Pharmacological characterization of the seven human NOX isoforms and their inhibitors.
Augsburger F; Filippova A; Rasti D; Seredenina T; Lam M; Maghzal G; Mahiout Z; Jansen-Dürr P; Knaus UG; Doroshow J; Stocker R; Krause KH; Jaquet V
Redox Biol; 2019 Sep; 26():101272. PubMed ID: 31330481
[TBL] [Abstract][Full Text] [Related]
43. Dysfunction of endothelial progenitor cells in hyperlipidemic rats involves the increase of NADPH oxidase derived reactive oxygen species production.
Li TB; Zhang JJ; Liu B; Luo XJ; Ma QL; Peng J
Can J Physiol Pharmacol; 2017 May; 95(5):474-480. PubMed ID: 28177697
[TBL] [Abstract][Full Text] [Related]
44. Phagocyte-like NADPH oxidase generates ROS in INS 832/13 cells and rat islets: role of protein prenylation.
Syed I; Kyathanahalli CN; Kowluru A
Am J Physiol Regul Integr Comp Physiol; 2011 Mar; 300(3):R756-62. PubMed ID: 21228337
[TBL] [Abstract][Full Text] [Related]
45. NADPH oxidase mediated oxidative stress in hepatic fibrogenesis.
Paik YH; Brenner DA
Korean J Hepatol; 2011 Dec; 17(4):251-7. PubMed ID: 22310788
[TBL] [Abstract][Full Text] [Related]
46. NADPH oxidases and inflammatory bowel disease.
Lam G; Apostolopoulos V; Zulli A; Nurgali K
Curr Med Chem; 2015; 22(17):2100-9. PubMed ID: 25876884
[TBL] [Abstract][Full Text] [Related]
47. NADPH oxidase activation is required in reactive oxygen species generation and cell transformation induced by hexavalent chromium.
Wang X; Son YO; Chang Q; Sun L; Hitron JA; Budhraja A; Zhang Z; Ke Z; Chen F; Luo J; Shi X
Toxicol Sci; 2011 Oct; 123(2):399-410. PubMed ID: 21742780
[TBL] [Abstract][Full Text] [Related]
48. Resveratrol protects vascular endothelial cells from high glucose-induced apoptosis through inhibition of NADPH oxidase activation-driven oxidative stress.
Chen F; Qian LH; Deng B; Liu ZM; Zhao Y; Le YY
CNS Neurosci Ther; 2013 Sep; 19(9):675-81. PubMed ID: 23731528
[TBL] [Abstract][Full Text] [Related]
49. Inhibiting NADPH Oxidases to Target Vascular and Other Pathologies: An Update on Recent Experimental and Clinical Studies.
Sylvester AL; Zhang DX; Ran S; Zinkevich NS
Biomolecules; 2022 Jun; 12(6):. PubMed ID: 35740948
[TBL] [Abstract][Full Text] [Related]
50. Dual oxidase 2 in lung epithelia is essential for hyperoxia-induced acute lung injury in mice.
Kim MJ; Ryu JC; Kwon Y; Lee S; Bae YS; Yoon JH; Ryu JH
Antioxid Redox Signal; 2014 Nov; 21(13):1803-18. PubMed ID: 24766345
[TBL] [Abstract][Full Text] [Related]
51. The NADPH oxidase family and its inhibitors.
Kleniewska P; Piechota A; Skibska B; Gorąca A
Arch Immunol Ther Exp (Warsz); 2012 Aug; 60(4):277-94. PubMed ID: 22696046
[TBL] [Abstract][Full Text] [Related]
52. NADPH oxidases as therapeutic targets in ischemic stroke.
Kahles T; Brandes RP
Cell Mol Life Sci; 2012 Jul; 69(14):2345-63. PubMed ID: 22618244
[TBL] [Abstract][Full Text] [Related]
53. The quest for selective nox inhibitors and therapeutics: challenges, triumphs and pitfalls.
Cifuentes-Pagano E; Meijles DN; Pagano PJ
Antioxid Redox Signal; 2014 Jun; 20(17):2741-54. PubMed ID: 24070014
[TBL] [Abstract][Full Text] [Related]
54. Calcium Release from Endoplasmic Reticulum Involves Calmodulin-Mediated NADPH Oxidase-Derived Reactive Oxygen Species Production in Endothelial Cells.
Sakurada R; Odagiri K; Hakamata A; Kamiya C; Wei J; Watanabe H
Int J Mol Sci; 2019 Apr; 20(7):. PubMed ID: 30987055
[TBL] [Abstract][Full Text] [Related]
55. Targeting Oxidative Stress for the Treatment of Liver Fibrosis.
Luangmonkong T; Suriguga S; Mutsaers HAM; Groothuis GMM; Olinga P; Boersema M
Rev Physiol Biochem Pharmacol; 2018; 175():71-102. PubMed ID: 29728869
[TBL] [Abstract][Full Text] [Related]
56. Atorvastatin attenuates homocysteine-induced apoptosis in human umbilical vein endothelial cells via inhibiting NADPH oxidase-related oxidative stress-triggered p38MAPK signaling.
Bao XM; Wu CF; Lu GP
Acta Pharmacol Sin; 2009 Oct; 30(10):1392-8. PubMed ID: 19767766
[TBL] [Abstract][Full Text] [Related]
57. Transforming growth factor β1 (TGFβ1)-induced CD44V6-NOX4 signaling in pathogenesis of idiopathic pulmonary fibrosis.
Ghatak S; Hascall VC; Markwald RR; Feghali-Bostwick C; Artlett CM; Gooz M; Bogatkevich GS; Atanelishvili I; Silver RM; Wood J; Thannickal VJ; Misra S
J Biol Chem; 2017 Jun; 292(25):10490-10519. PubMed ID: 28389561
[TBL] [Abstract][Full Text] [Related]
58. Ellagic acid inhibits oxidized LDL-mediated LOX-1 expression, ROS generation, and inflammation in human endothelial cells.
Lee WJ; Ou HC; Hsu WC; Chou MM; Tseng JJ; Hsu SL; Tsai KL; Sheu WH
J Vasc Surg; 2010 Nov; 52(5):1290-300. PubMed ID: 20692795
[TBL] [Abstract][Full Text] [Related]
59. The Dual Role of Reactive Oxygen Species-Generating Nicotinamide Adenine Dinucleotide Phosphate Oxidases in Gastrointestinal Inflammation and Therapeutic Perspectives.
Dang PM; Rolas L; El-Benna J
Antioxid Redox Signal; 2020 Aug; 33(5):354-373. PubMed ID: 31968991
[No Abstract] [Full Text] [Related]
60. NADPH oxidase inhibition rescues keratinocytes from elevated oxidative stress in a 2D atopic dermatitis and psoriasis model.
Emmert H; Fonfara M; Rodriguez E; Weidinger S
Exp Dermatol; 2020 Aug; 29(8):749-758. PubMed ID: 32640089
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
